11/21
10:18 pm
rmd
ResMed expands Singapore operations to address obstructive sleep conditions [CNBC]
Neutral
Report
ResMed expands Singapore operations to address obstructive sleep conditions [CNBC]
11/21
11:28 am
rmd
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar [Yahoo! Finance]
Low
Report
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar [Yahoo! Finance]
11/19
09:57 am
rmd
Rebalance Health Demonstrates Significant Sleep Benefits in New Blind Placebo Study [Yahoo! Finance]
Low
Report
Rebalance Health Demonstrates Significant Sleep Benefits in New Blind Placebo Study [Yahoo! Finance]
11/18
08:22 am
rmd
ResMed's (NYSE:RMD) earnings growth rate lags the 11% CAGR delivered to shareholders [Yahoo! Finance]
Low
Report
ResMed's (NYSE:RMD) earnings growth rate lags the 11% CAGR delivered to shareholders [Yahoo! Finance]
11/15
10:47 am
rmd
Here's Why You Should Add RMD Stock to Your Portfolio Now [Yahoo! Finance]
Low
Report
Here's Why You Should Add RMD Stock to Your Portfolio Now [Yahoo! Finance]
11/15
08:01 am
rmd
It's True: Women Need More Sleep Than Men [CNET News]
Low
Report
It's True: Women Need More Sleep Than Men [CNET News]
11/14
08:22 am
rmd
Insiders At ResMed Sold US$16m In Stock, Alluding To Potential Weakness [Yahoo! Finance]
Low
Report
Insiders At ResMed Sold US$16m In Stock, Alluding To Potential Weakness [Yahoo! Finance]
11/13
12:21 pm
rmd
Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours [Yahoo! Finance]
Low
Report
Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours [Yahoo! Finance]
11/12
09:00 am
rmd
Exploring the $188 Billion Opportunity: Why AI is Set to Transform Global Healthcare by 2030
Low
Report
Exploring the $188 Billion Opportunity: Why AI is Set to Transform Global Healthcare by 2030
11/12
09:00 am
rmd
Exploring the $188 Billion Opportunity: Why AI is Set to Transform Global Healthcare by 2030
Low
Report
Exploring the $188 Billion Opportunity: Why AI is Set to Transform Global Healthcare by 2030
11/8
06:19 am
rmd
With 74% ownership, ResMed Inc. (NYSE:RMD) boasts of strong institutional backing [Yahoo! Finance]
Low
Report
With 74% ownership, ResMed Inc. (NYSE:RMD) boasts of strong institutional backing [Yahoo! Finance]
11/5
04:05 pm
rmd
ResMed Announces Participation in the UBS Global Healthcare Conference
Low
Report
ResMed Announces Participation in the UBS Global Healthcare Conference
11/3
07:57 am
rmd
Should You Buy ResMed Inc. (NYSE:RMD) For Its Upcoming Dividend? [Yahoo! Finance]
Low
Report
Should You Buy ResMed Inc. (NYSE:RMD) For Its Upcoming Dividend? [Yahoo! Finance]
10/29
08:30 am
rmd
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of ResMed Inc. (NYSE:RMD) and Encourages Investors to Contact the Firm
Low
Report
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of ResMed Inc. (NYSE:RMD) and Encourages Investors to Contact the Firm
10/28
01:54 pm
rmd
PHG vs. RMD: Which Stock Should Value Investors Buy Now? [Yahoo! Finance]
Low
Report
PHG vs. RMD: Which Stock Should Value Investors Buy Now? [Yahoo! Finance]
10/28
10:45 am
rmd
ResMed Inc. (RMD) Hits Fresh High: Is There Still Room to Run? [Yahoo! Finance]
Low
Report
ResMed Inc. (RMD) Hits Fresh High: Is There Still Room to Run? [Yahoo! Finance]
10/25
01:45 pm
rmd
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $251.00 to $266.00. They now have an "overweight" rating on the stock.
Low
Report
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $251.00 to $266.00. They now have an "overweight" rating on the stock.
10/25
01:44 pm
rmd
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Royal Bank of Canada from $224.00 to $232.00. They now have a "sector perform" rating on the stock.
Low
Report
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Royal Bank of Canada from $224.00 to $232.00. They now have a "sector perform" rating on the stock.
10/25
11:35 am
rmd
Sleep Apnea Device Maker ResMed Is A Durable MedTech, With Positive Fundamentals, Says Analyst [Yahoo! Finance]
Low
Report
Sleep Apnea Device Maker ResMed Is A Durable MedTech, With Positive Fundamentals, Says Analyst [Yahoo! Finance]
10/25
09:39 am
rmd
ResMed's Stock Rises on Q1 Earnings and Revenue Beat, Margins Expand [Yahoo! Finance]
Low
Report
ResMed's Stock Rises on Q1 Earnings and Revenue Beat, Margins Expand [Yahoo! Finance]
10/25
08:37 am
rmd
ResMed Inc. (NYSE: RMD) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Low
Report
ResMed Inc. (NYSE: RMD) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
10/25
08:37 am
rmd
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Robert W. Baird from $280.00 to $283.00. They now have an "outperform" rating on the stock.
Low
Report
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Robert W. Baird from $280.00 to $283.00. They now have an "outperform" rating on the stock.
10/24
11:17 pm
rmd
ResMed Inc. (RMD) Q1 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
ResMed Inc. (RMD) Q1 2025 Earnings Call Transcript [Seeking Alpha]
10/24
07:32 pm
rmd
ResMed (RMD) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
Low
Report
ResMed (RMD) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
10/24
04:05 pm
rmd
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
Medium
Report
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025